FibroTest showed low accuracy in detecting
significant fibrosis and cirrhosis among patients with chronic hepatitis
B-related cirrhosis, according to results from a meta-analysis.
Nermin N. Salkic, MD, PhD,
department of gastroenterology and hepatology, University Clinical
Center Tuzla, Bosnia and Herzegovina, and colleagues included 16 studies
with 2,494 patients after searching Medline, Embase and Cochrane
Library databases. Studies were used in a hierarchical summary receiver
operating curve model to determine the presence of liver fibrosis,
while 13 of the studies (n=1,754) were included in a different
hierarchical summary receiver operating curve model to assess liver cirrhosis.
“FibroTest is of excellent utility for excluding cirrhosis in patients with chronic hepatitis B,” Salkic told Healio.com/Hepatology.
“The diagnostic performance of FibroTest in detection of significant
fibrosis and cirrhosis and exclusion of significant fibrosis is
suboptimal. It is important for clinicians to adhere to the recommended
thresholds of FibroTest until better ones are derived.”
Labels: diagnostic tools, FibroTest accuracy